{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:43:15Z","timestamp":1790214195146,"version":"4.1.0"},"reference-count":29,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.3892\/mmr.2017.6960","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T13:09:41Z","timestamp":1499864981000},"page":"3573-3580","source":"Crossref","is-referenced-by-count":51,"title":["KDM5A promotes proliferation and EMT in ovarian cancer and closely correlates with PTX resistance"],"prefix":"10.3892","volume":"16","author":[{"given":"Tongfu","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,7,12]]},"reference":[{"key":"key20180108002547_b1-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"key20180108002547_b2-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.6004\/jnccn.2013.0142","article-title":"Ovarian cancer, version 2.2013","volume":"11","author":"Morgan","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"key20180108002547_b3-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3322\/caac.21235","article-title":"Cancer treatment and survivorship statistics, 2014","volume":"64","author":"DeSantis","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"key20180108002547_b4-mmr-16-03-3573","first-page":"4443","article-title":"Rational selection of predictive pharmacogenomics test for the Fluoropyrimidine\/Oxaliplatin based therapy","volume":"19","author":"Di Francia","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key20180108002547_b5-mmr-16-03-3573","first-page":"2084","article-title":"Underlying mechanism of 2-methoxyestradiol-induced apoptosis and growth arrest in SKOV3 human ovarian cancer cells","volume":"19","author":"Ding","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key20180108002547_b6-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.18632\/oncotarget.6546","article-title":"miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma","volume":"7","author":"Sestito","year":"2016","journal-title":"Oncotarget"},{"key":"key20180108002547_b7-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/onc.2015.84","article-title":"miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin","volume":"35","author":"Zhu","year":"2016","journal-title":"Oncogene"},{"key":"key20180108002547_b8-mmr-16-03-3573","first-page":"818","article-title":"The histone deacetylase SIRT6 inhibits ovarian cancer cell proliferation via down-regulation of Notch 3 expression","volume":"19","author":"Zhang","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key20180108002547_b9-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.molonc.2014.03.016","article-title":"Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers","volume":"8","author":"Moisan","year":"2014","journal-title":"Mol Oncol"},{"key":"key20180108002547_b10-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"9671","DOI":"10.1007\/s13277-016-4848-x","article-title":"NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer","volume":"37","author":"Liu","year":"2016","journal-title":"Tumour Biol"},{"key":"key20180108002547_b11-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"key20180108002547_b12-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.cell.2007.02.003","article-title":"RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3","volume":"128","author":"Christensen","year":"2007","journal-title":"Cell"},{"key":"key20180108002547_b13-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.molcel.2008.08.004","article-title":"Genome-wide analysis of the H3K4 histone demethylase RBP2 reveals a transcriptional program controlling differentiation","volume":"31","author":"Lopez-Bigas","year":"2008","journal-title":"Mol Cell"},{"key":"key20180108002547_b14-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1101\/gad.470008","article-title":"Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and polycomb-repressive complex 2","volume":"22","author":"Pasini","year":"2008","journal-title":"Genes Dev"},{"key":"key20180108002547_b15-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/352251a0","article-title":"Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product","volume":"352","author":"Defeo-Jones","year":"1991","journal-title":"Nature"},{"key":"key20180108002547_b16-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/genetics\/156.2.645","article-title":"A screen for new trithorax group genes identified little imaginal discs, the Drosophila melanogaster homologue of human retinoblastoma binding protein 2","volume":"156","author":"Gildea","year":"2000","journal-title":"Genetics"},{"key":"key20180108002547_b17-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/j.gastro.2009.10.004","article-title":"The histone demethylase RBP2 Is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells","volume":"138","author":"Zeng","year":"2010","journal-title":"Gastroenterology"},{"key":"key20180108002547_b18-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"13379","DOI":"10.1073\/pnas.1110104108","article-title":"Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1","volume":"108","author":"Lin","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108002547_b19-mmr-16-03-3573","first-page":"247","article-title":"Genomic amplification and a role in drug- resistance for the KDM5A histone demethylase in breast cancer","volume":"4","author":"Hou","year":"2012","journal-title":"Am J Transl Res"},{"key":"key20180108002547_b20-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1038\/onc.2009.297","article-title":"Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer","volume":"28","author":"Liu","year":"2009","journal-title":"Oncogene"},{"key":"key20180108002547_b21-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations","volume":"141","author":"Sharma","year":"2010","journal-title":"Cell"},{"key":"key20180108002547_b22-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1080\/15384101.2015.1090063","article-title":"The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma","volume":"14","author":"Banelli","year":"2015","journal-title":"Cell Cycle"},{"key":"key20180108002547_b23-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits","volume":"9","author":"Polyak","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"key20180108002547_b24-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.prp.2015.05.010","article-title":"Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review","volume":"211","author":"Cao","year":"2015","journal-title":"Pathol Res Pract"},{"key":"key20180108002547_b25-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(13)61502-0","article-title":"Management of non-small-cell lung cancer: Recent developments","volume":"382","author":"Reck","year":"2013","journal-title":"Lancet"},{"key":"key20180108002547_b26-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"e113478","DOI":"10.1371\/journal.pone.0113478","article-title":"Overexpression of forkhead box protein M1 (FOXM1) in ovarian cancer correlates with poor patient survival and contributes to paclitaxel resistance","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"key":"key20180108002547_b27-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1158\/1078-0432.CCR-09-2399","article-title":"Targeting histone demethylases in cancer therapy","volume":"15","author":"Grant","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180108002547_b28-mmr-16-03-3573","first-page":"607","article-title":"The future therapeutic potential of histone demethylases: A critical analysis","volume":"12","author":"Natoli","year":"2009","journal-title":"Curr Opin Drug Discov Devel"},{"key":"key20180108002547_b29-mmr-16-03-3573","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc1123","article-title":"Ovarian cancer: Strategies for overcoming resistance to chemotherapy","volume":"3","author":"Agarwal","year":"2003","journal-title":"Nat Rev Cancer"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T20:57:12Z","timestamp":1659214632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.6960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,7,12]]},"published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.3892\/mmr.2017.6960"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.6960","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}